Details for Patent: 7,932,241
✉ Email this page to a colleague
Which drugs does patent 7,932,241 protect, and when does it expire?
Patent 7,932,241 protects ZOMETA and RECLAST and is included in two NDAs.
Protection for RECLAST has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-six patent family members in twenty-two countries.
Summary for Patent: 7,932,241
| Title: | Pharmaceutical products comprising bisphosphonates |
| Abstract: | A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of a ready to use infusion solution, for administration of the bisphosphonate to a patient in need of bisphosphonate treatment. |
| Inventor(s): | Alexandra Glausch, Rolf Löffler, Juergen Sigg |
| Assignee: | Novartis Pharmaceuticals Corp |
| Application Number: | US10/570,339 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,932,241 |
|
Patent Claim Types: see list of patent claims | Compound; Process; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 7,932,241
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ZOMETA | zoledronic acid | INJECTABLE;INTRAVENOUS | 021223-003 | Jun 17, 2011 | DISCN | Yes | No | 7,932,241 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Sandoz | RECLAST | zoledronic acid | INJECTABLE;INTRAVENOUS | 021817-001 | Apr 16, 2007 | AP | RX | Yes | Yes | 7,932,241*PED | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,932,241
| PCT Information | |||
| PCT Filed | September 17, 2004 | PCT Application Number: | PCT/EP2004/010470 |
| PCT Publication Date: | March 24, 2005 | PCT Publication Number: | WO2005/025551 |
International Family Members for US Patent 7,932,241
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 045670 | ⤷ Start Trial | |||
| Australia | 2004271731 | ⤷ Start Trial | |||
| Brazil | PI0414562 | ⤷ Start Trial | |||
| Canada | 2536206 | ⤷ Start Trial | |||
| China | 1852739 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
